Product Categories
| Country: | China |
|---|---|
| Tel: | 177-54423994 |
| Mobile: | 17754423994 |
| E-mail: | 2853530910@QQ.com |
| QQ: | 2853530910 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Socazolimab | 2305043-30-3 | Details |
| Xeligekimab | 2382921-73-3 | Details |
| Galegenimab | 2403683-24-7 | Details |
| Disitertide | C68H109N17O22S2 | 272105-42-7 | Details |
| 3-(Bromomethyl)-3-(chloromethyl)oxetane | C5H8BrClO | 35842-60-5 | Details |
| RSVA 405 | C17H20N4O2 | 140405-36-3 | Details |
| WAY-624704 | C17H15N3O2S | 692869-38-8 | Details |
| BV02 | C20H15N3O5 | 292870-53-2 | Details |
| IHMT-PI3Kδ-372 | C26H23F2N7O2 | 2429889-62-1 | Details |
| Recombinant Protein A | 91932-65-9 | Details |
| FCPR03 | C15H19F2NO3 | 1917347-65-9 | Details |
| NPS 2390 | C19H21N3O | 226878-01-9 | Details |
| Tirnovetmab | 2364504-80-1 | Details |
| Zansecimab | 2415205-37-5 | Details |
| Gresonitamab | 2413817-97-5 | Details |
| Ivonescimab | 2428381-53-5 | Details |
| Livmoniplimab | 2412004-88-5 | Details |
| BTT-266 | Details |
| Polatuzumab Vedotin | 1313206-42-6 | Details |
| Runimotamab | 2361325-98-4 | Details |
| Imsidolimab | 2102543-86-0 | Details |
| Sibeprenlimab | 2382896-07-1 | Details |
| Uliledlimab | 2378407-27-1 | Details |
| Mupadolimab | 2451856-97-4 | Details |
| Nofazinlimab | 2377845-98-0 | Details |
| Anselamimab | 2414866-63-8 | Details |
| N-(1-Oxoheptyl)glycine Ethyl Ester | C11H21NO3 | 574010-47-2 | Details |
| FLLL31 | C25H28O6 | 52328-97-9 | Details |
| COH-SR4 | C13H8Cl4N2O | 73439-19-7 | Details |
| BAY-3827 | C27H25FN6O | 2377576-35-5 | Details |
| BHQ-1 NHS | C30H31N7O7 | 916753-61-2 | Details |
| BHQ-3 acid | C33H35N6O2+ | 1338332-66-3 | Details |
| ONC-201 Dihydrochloride | C24H27ClN4O | 1638178-82-1 | Details |
| VPC-18005 | C15H17N3O3S | 2242480-48-2 | Details |
| Pavunalimab | 2329669-78-3 | Details |
| Elranatamab | 2408850-14-4 | Details |
| Gumokimab | 2428381-52-4 | Details |
| Sotevtamab | 2411526-47-9 | Details |
| Ro 5-3335 | C13H10ClN3O | 30195-30-3 | Details |
| CAIX Inhibitor S4 | C15H17N3O4S | 1330061-67-0 | Details |
| ARC 239 dihydrochloride | C24H30ClN3O3 | 55974-42-0 | Details |
| G5-7 | C22H19F2NO3 | 939681-36-4 | Details |
| BHQ-1 amine | C25H29N7O3 | 1308657-79-5 | Details |
| FATP1-IN-1 | C18H22FN5OS | 1431945-95-7 | Details |
| Zilovertamab | 2485779-13-1 | Details |
| Fidasimtamab | 2377419-89-9 | Details |
| Pivekimab | 2234335-84-1 | Details |
| Aminopurvalanol A | C19H26ClN7O | 220792-57-4 | Details |
| NS1738 | C14H9Cl2F3N2O2 | 501684-93-1 | Details |
| 5-HT3 antagonist-4i | C16H12ClN3O | 930478-88-9 | Details |
| DMU2139 | C19H15NO2 | 1821143-80-9 | Details |
| ALLO-2 | C18H12F3N5O | 1357350-60-7 | Details |
| NH-3 | C28H27NO6 | 447415-26-1 | Details |
| SC99 | C15H8Cl2FN3O | 882290-02-0 | Details |
| 1-Piperazinyl(3-pyridinyl)methanone | C10H13N3O | 39640-08-9 | Details |
| BMS-986235 | C18H17F2N3O3 | 2253947-47-4 | Details |
| Box5 | C25H42N6O11S2 | 881188-48-3 | Details |
| BHQ-3 NHS | C37H38N7O4+ | 871240-94-7 | Details |
| MERS-CoV-IN-1 | C19H17NO2 | 2245697-92-9 | Details |
| Sotigalimab | 2305607-45-6 | Details |
| Ubamatamab | 2305629-50-7 | Details |
| Rulonilimab | 2417124-95-7 | Details |
| MF 438 | C19H18F3N5OS | 921605-87-0 | Details |
| IPI-9119 | C24H19F2N5O5 | 1346564-56-4 | Details |
| Vazegepant hydrochloride | C36H47ClN8O3 | 1414976-20-7 | Details |
| Moxetumomab Pasudotox | 1020748-57-5 | Details |
| 6-(Dimethylamino)quinoline-2-carbaldehyde | C12H12N2O | 1267631-83-3 | Details |
| BHQ-1 acid | C26H28N6O5 | 1190431-95-8 | Details |
| (E)-Akt inhibitor-IV | C31H27IN4S | 959841-49-7 | Details |
| Plonmarlimab | 2377482-36-3 | Details |
| Simridarlimab | 2378862-90-7 | Details |
| Ulenistamab | 2415259-90-2 | Details |
| KG5 | C20H16F3N7OS | 877874-85-6 | Details |
| E7016 | C20H19N3O3 | 902128-92-1 | Details |
| Cdk2/9 Inhibitor | C14H12N6O2S | 507487-89-0 | Details |
| NSAH | C18H14N2O3 | 1099592-35-4 | Details |
| BHQ-2 amine | C24H27N7O4 | 1241962-11-7 | Details |
| Lorigerlimab | 2416595-46-3 | Details |
| Ginisortamab | 2390147-17-6 | Details |
| Mirodenafil dihydrochloride | C26H37N5O5S | 862189-96-6 | Details |
| TC LPA5 4 | C23H23ClN2O3 | 1393814-38-4 | Details |
| Ubiquitination-IN-1 | C21H14F3N3O2S | 1819330-15-8 | Details |
| WAY-119064 | C12H12N2O3S | 1198098-03-1 | Details |
| ACT-1004-1239 | C27H28F2N6O3 | 2178049-58-4 | Details |
| NiCur | C22H16N2O | 63476-70-0 | Details |
| ACT-451840 | C47H54N6O3 | 1984890-99-4 | Details |
| Surzebiclimab | 2342597-90-2 | Details |
| Vixarelimab | 2243320-83-2 | Details |
| Voxalatamab | 2411871-58-2 | Details |
| Iparomlimab | 2417649-33-1 | Details |
| Tecaginlimab | 2253891-70-0 | Details |
| 2-Bromo-N-propylacetamide | C5H10BrNO | 5395-67-5 | Details |
| GR 46611 | C23H27N3O2 | 185259-85-2 | Details |
| Obrindatamab | 2069959-72-2 | Details |
| Idactamab | 2245205-37-0 | Details |
| Tusamitamab | 2349294-95-5 | Details |
| Dresbuxelimab | 2550560-20-6 | Details |
| Vepsitamab | 2413453-53-7 | Details |
| Ivicentamab | 2364496-42-2 | Details |
| BHQ-3 amine | C32H36N7+ | 1661064-89-6 | Details |
| Product Total： Product Page： | ||||
| 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 | ||||